Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy
NCT07096986
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Nice, France
View Trial DetailsNCT Number: NCT07783737
This is a prospective observational study aimed at establishing a prospective observational cohort of patients with a confirmed diagnosis of glomerulonephritis (GN) before kidney transplantation in China. Information will be collected on the epidemiology of GN recurrence after kidney transplantation, as well as the outcomes and treatment of the primary disease following kidney transplantation, to provide evidence for subsequent clinical studies, drug development, and translational research.
Approximately 300 patients with a confirmed diagnosis of GN before transplantation will be prospectively enrolled. Clinical data will be collected during screening, kidney transplantation, and a 3-year post-transplant follow-up. The frequency of follow-up visits is every 3 months in the 1st year after transplantation, and every 6 months during the 2nd to 3rd years, with a total of 8 follow-up visits. The study will be conducted at 10 sites across China.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3-year follow-up
Incidence of GN recurrence after kidney transplantation
Time frame: 3-year follow-up
Time to GN recurrence after kidney transplantation (months)
Time frame: 3-year follow-up
Factors associated with GN recurrence after kidney transplantation
Time frame: 3-year follow-up
incidence and time to rejection
Time frame: 3-year follow-up
incidence and time to renal allograft loss
Time frame: 3-year follow-up
incidence and time to death
Trial opening soon.
Get NotifiedAstraZeneca
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07096986
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Nice, France
View Trial DetailsNCT07642050
Autoimmune Diseases, Chronic Disease
View Trial DetailsNCT07431931
Albuminuria, Female Urogenital Diseases
Danville, Pennsylvania, United States
View Trial DetailsNCT06792448
Blood Protein Disorders, Chronic Disease
View Trial Details